Homepage Flash

CorMatrix ECM Technology has been used at more than 500 hospitals across the U.S. and has been implanted in nearly 40,000 cardiac procedures.

This naturally occurring extracellular matrix biomaterial supports native tissue repair by providing an interim bioscaffold, that enables a patient's own cells to repopulate and repair damaged tissues.

Watch how ECM Technology helps repair damaged heart tissue

Launch Video

January 28-29, 2012
Fort Lauderdale, FL

STS/AATS Tech-Con 2012 »

January 30-01, 2012
Fort Lauderdale, FL

Society of Thoracic Surgeons (STS) 48th Annual Meeting »

April 18-21, 2012
Prague, Czech Republic

The International Society for Heart & Lung Transplant (ISHLT) »

CorMatrix ECM Video

CorMatrix is dedicated to developing and delivering unique extracellular matrix (ECM®) biomaterial technologies that harness the body's innate ability to repair damaged cardiovascular tissue.